|
RHOT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.782800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.418270E-02 |
| Normal-vs-Stage2 |
5.918800E-01 |
| Normal-vs-Stage3 |
1.430500E-04 |
| Normal-vs-Stage4 |
5.601300E-04 |
| Stage1-vs-Stage2 |
1.085830E-01 |
| Stage1-vs-Stage3 |
3.215700E-02 |
| Stage1-vs-Stage4 |
1.205170E-01 |
| Stage2-vs-Stage3 |
4.763700E-03 |
| Stage2-vs-Stage4 |
1.430220E-02 |
| Stage3-vs-Stage4 |
9.295800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.784000E-04 |
| Normal-vs-AfricanAmerican |
3.508400E-01 |
| Normal-vs-Asian |
7.881900E-02 |
| Caucasian-vs-AfricanAmerican |
1.326030E-01 |
| Caucasian-vs-Asian |
2.259400E-01 |
| AfricanAmerican-vs-Asian |
6.332800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.803700E-04 |
| Normal-vs-Female |
9.797600E-03 |
| Male-vs-Female |
2.802400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.171800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.017600E-03 |
| Normal-vs-Age(61-80Yrs) |
8.355600E-03 |
| Normal-vs-Age(81-100Yrs) |
3.717200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.444430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.336800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.672300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.002800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.119000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.907700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.073200E-01 |
| Classical-VS-Follicular |
1.217420E-03 |
| Classical-VS-Other |
8.054200E-01 |
| Classical-VS-Normal |
1.275720E-03 |
| Tall-VS-Follicular |
1.196590E-04 |
| Tall-VS-Other |
2.329200E-01 |
| Tall-VS-Normal |
2.444200E-04 |
| Follicular-VS-Other |
3.970800E-01 |
| Follicular-VS-Normal |
9.876800E-01 |
| Other-VS-Normal |
2.833800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.115700E-02 |
| Normal-vs-N1 |
1.080040E-03 |
| N0-vs-N1 |
1.329960E-01 |
|
|
